Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) was associated with a 54 percent reduction in the composite endpoint of death, myocardial infarction and urgent revascularization when compared to medical therapy alone, according to five-year data from the FAME 2 trial.

A poll conducted by the Medical Group Management Association (MGMA) found most medical practice professionals aren’t aware of the direct primary care (DPC) model where patients pay a flat fee in exchange for easier access to their primary care doctor.

The American Hospital Association (AHA) is lending its support to a bill to change the merger review process at the Federal Trade Commission (FTC), eliminating the agency’s ability to challenge proposed combinations without going to court.

The Medical Imaging and Technology Alliance (MITA) announced its support of the FDA's recent decision to promote the adoption of quality management principles in medical equipment servicing, according to a statement released May 15.

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

An expert consensus document published May 2 in the Journal of the American College of Cardiology offers recommendations for limiting radiation exposure to both patients and medical personnel during cardiovascular imaging procedures.